SCHEMBL16413878

SCHEMBL16413878

CCN(c1ccc(/N=C2\C=C(Nc3ccc(N(CC)C(C)C)cc3)C(=O)C=C2O)cc1)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 1/20 0.37
▸ MAPT P10636 8/20 0.36
▸ L3MBTL1 Q9Y468 6/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ ALDH1A1 P00352 10/20 0.35
▸ MCL1 Q07820 4/20 0.35
▸ HTT P42858 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ P2RX3 P56373 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ GPR55 Q9Y2T6 1/20 0.34
▸ APAF1 O14727 3/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16413881 1.00 DNM1 (0.37) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL16426691 1.00 DNM1 (0.37) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15020128 0.90 ALDH1A1 (0.37) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15020129 0.90 ALDH1A1 (0.37) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL17253269 0.90 ALDH1A1 (0.37) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15019824 0.87 ALDH1A1 (0.35) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15020144 0.87 ALDH1A1 (0.35) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15020117 0.87 ALDH1A1 (0.35) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL17253298 0.87 ALDH1A1 (0.35) DNM1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15039492 0.87 ALDH1A1 (0.35) DNM1MAPTL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9439844-B2 Tri-aromatic azomethine direct dyes comprising at least one unit derived from resorcinol, dyeing composition, method and use L'OREAL (FR) 2016-09-13 — — US claimed
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2015-01-29 — — US claimed
US-9439844-B2 Tri-aromatic azomethine direct dyes comprising at least one unit derived from resorcinol, dyeing composition, method and use L'OREAL (FR) 2016-09-13 — — US disclosed
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2015-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE KRT18, IK, MKI67 DNM1 2954/4885MAPT 132/4885L3MBTL1 4835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback